Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Case Reports in Hematology
|
September 1, 2012
Response of paroxysmal nocturnal hemoglobinuria clone with aplastic anemia to rituximab
Radha Raghupathy, Olga Derman
Biomarker Research
|
October 26, 2016
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?
Kenneth G Liu, Amit Verma, Olga Derman, et al.
Clinical Case Reports
|
June 8, 2017
Ibrutinib-induced severe liver injury
Amara G Nandikolla, Olga Derman, Deborah Nautsch, et al.
Leukemia & Lymphoma
|
July 4, 2018
Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell transplant - a case series
Diego Adrianzen Herrera, Sabarish Ayyappan, Sakshi Jasra, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2019
Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts
Diego Adrianzen Herrera, Noah Kornblum, Olga Derman, et al.
American Journal of Hematology
|
July 5, 2017
Stimulation of adrenergic activity by desipramine enhances hematopoietic stem and progenitor cell mobilization along with G-CSF in multiple myeloma: A pilot study
Aditi Shastri, Anjali Budhathoki, Stefan K Barta, et al.
Case Reports in Oncological Medicine
|
January 12, 2019
Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
Urvi A Shah, Sengottuvel Viswanathan, Beamon Agarwal, et al.
Oncotarget
|
June 25, 2016
Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy
Monica Zell, Amer Assal, Olga Derman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 8, 2017
Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma
Stefan K Barta, Rishi Jain, Amithaba Mazumder, et al.
Leukemia & Lymphoma
|
February 18, 2016
Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor
Amer Assal, Baoxia Dong, Hina Khan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Case Reports in Hematology
|
September 1, 2012
Response of paroxysmal nocturnal hemoglobinuria clone with aplastic anemia to rituximab
Radha Raghupathy, Olga Derman
Biomarker Research
|
October 26, 2016
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?
Kenneth G Liu, Amit Verma, Olga Derman, et al.
Clinical Case Reports
|
June 8, 2017
Ibrutinib-induced severe liver injury
Amara G Nandikolla, Olga Derman, Deborah Nautsch, et al.
Leukemia & Lymphoma
|
July 4, 2018
Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell transplant - a case series
Diego Adrianzen Herrera, Sabarish Ayyappan, Sakshi Jasra, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2019
Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts
Diego Adrianzen Herrera, Noah Kornblum, Olga Derman, et al.
American Journal of Hematology
|
July 5, 2017
Stimulation of adrenergic activity by desipramine enhances hematopoietic stem and progenitor cell mobilization along with G-CSF in multiple myeloma: A pilot study
Aditi Shastri, Anjali Budhathoki, Stefan K Barta, et al.
Case Reports in Oncological Medicine
|
January 12, 2019
Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
Urvi A Shah, Sengottuvel Viswanathan, Beamon Agarwal, et al.
Oncotarget
|
June 25, 2016
Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy
Monica Zell, Amer Assal, Olga Derman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 8, 2017
Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma
Stefan K Barta, Rishi Jain, Amithaba Mazumder, et al.
Leukemia & Lymphoma
|
February 18, 2016
Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor
Amer Assal, Baoxia Dong, Hina Khan, et al.
Page
of 2